The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrepresented communities. The resulting materials are available and accessible on the 3CTN website for the benefit of all in the research community. To access, please go to https://3ctn.ca/equity-diversity-and-inclusion-in-clinical-trials/.
New Scientific Director for CIHR’s Institute of Cancer Research
Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation... Read More »
Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation... Read More »
Community Event in Halifax on November 11
Did you know that the CCRA is offering a free, all-ages cancer awareness event to people in the Halifax and surrounding communities on the afternoon of November 11 at the Halifax Convention Centre? Featuring exhibits from many organizations, thi... Read More »
Did you know that the CCRA is offering a free, all-ages cancer awareness event to people in the Halifax and surrounding communities on the afternoon of November 11 at the Halifax Convention Centre? Featuring exhibits from many organizations, thi... Read More »